Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Rubens

Showing results (301-310 of 415) with videos related to

Pageof 42
Sort By:
Thrombosis and Haemostasis|August 1, 1994
Displacement of fibrin-bound thrombin by r-hirudin precludes the use of 131I-r-hirudin for detecting pulmonary emboli in the rabbitF D Rubens, B Ross-Ouellet, C Dennie, et al.
British Journal of Cancer|November 1, 1993
Chemotherapy of advanced breast cancer: outcome and prognostic factorsW M Gregory, P Smith, M A Richards, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1983
Adriamycin alone or combined with vincristine in the treatment of advanced breast cancerR Steiner, J F Stewart, B M Cantwell, et al.
Journal of Thoracic Imaging|April 9, 2004
Chronic thromboembolic pulmonary arterial hypertension: correlation of postoperative results of thromboendarterectomy with preoperative helical contrast-enhanced computed tomographyAnastasia Oikonomou, Carole J Dennie, Nestor L Müller, et al.
Clinical Oncology|December 1, 1979
Relation between endocrine function and survival of patients with breast cancer after hypophysectomyD Y Wang, R D Bulbrook, R D Rubens, et al.
Circulation|July 6, 2006
Predictors of early neurocognitive deficits in low-risk patients undergoing on-pump coronary artery bypass surgeryMunir Boodhwani, Fraser D Rubens, Denise Wozny, et al.
British Journal of Cancer|May 1, 1992
Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone diseaseR E Coleman, S Houston, I James, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
High-dose epirubicin as primary chemotherapy in advanced breast carcinoma: a phase II studyJ Carmo-Pereira, F O Costa, D W Miles, et al.
British Journal of Cancer|March 31, 1999
Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancerS J Houston, T A Plunkett, D M Barnes, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Comparative pharmacokinetics of doxorubicin given by three different schedules with equal dose intensity in patients with breast cancerC J Twelves, N A Dobbs, M Aldhous, et al.
Pageof 42

Showing results (301-310 of 415) with videos related to

Sort By:
Pageof 42
Thrombosis and Haemostasis|August 1, 1994
Displacement of fibrin-bound thrombin by r-hirudin precludes the use of 131I-r-hirudin for detecting pulmonary emboli in the rabbitF D Rubens, B Ross-Ouellet, C Dennie, et al.
British Journal of Cancer|November 1, 1993
Chemotherapy of advanced breast cancer: outcome and prognostic factorsW M Gregory, P Smith, M A Richards, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1983
Adriamycin alone or combined with vincristine in the treatment of advanced breast cancerR Steiner, J F Stewart, B M Cantwell, et al.
Journal of Thoracic Imaging|April 9, 2004
Chronic thromboembolic pulmonary arterial hypertension: correlation of postoperative results of thromboendarterectomy with preoperative helical contrast-enhanced computed tomographyAnastasia Oikonomou, Carole J Dennie, Nestor L Müller, et al.
Clinical Oncology|December 1, 1979
Relation between endocrine function and survival of patients with breast cancer after hypophysectomyD Y Wang, R D Bulbrook, R D Rubens, et al.
Circulation|July 6, 2006
Predictors of early neurocognitive deficits in low-risk patients undergoing on-pump coronary artery bypass surgeryMunir Boodhwani, Fraser D Rubens, Denise Wozny, et al.
British Journal of Cancer|May 1, 1992
Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone diseaseR E Coleman, S Houston, I James, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
High-dose epirubicin as primary chemotherapy in advanced breast carcinoma: a phase II studyJ Carmo-Pereira, F O Costa, D W Miles, et al.
British Journal of Cancer|March 31, 1999
Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancerS J Houston, T A Plunkett, D M Barnes, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Comparative pharmacokinetics of doxorubicin given by three different schedules with equal dose intensity in patients with breast cancerC J Twelves, N A Dobbs, M Aldhous, et al.
Pageof 42